Respiratory syncytial virus (RSV) is a common cause of acute respiratory tract infections which are usually mild and self-limiting. Symptoms usually include runny nose, cough and fever.
For infants and older adults however, the virus can lead to more severe illness and hospitalisation. In infants, RSV can cause bronchiolitis (inflammation and narrowing of the small airways in the lungs), which can lead to significant breathing difficulties and difficulties feeding.
RSV is highly infectious and is transmitted via respiratory droplets (coughing, sneezing), through close contact with an infected person or contact with contaminated surfaces.
During Pregnancy
From 1 September 2024, the RSV vaccine should be offered to every pregnant woman from week 28 of their pregnancy. All women who are already at least 28 weeks pregnant on 1 September 2024 should be vaccinated as soon as possible.
For more information, please click on the link below: